Rossari Biotech Ltd Stock Analysis

BSE: 543213 | NSE: ROSSARI | Chemicals | Small Cap

BSE Share Price 06-Feb-2023 11:58
691.70 1.30 (0.19%)

DeciZen - Make an Informed Decision on Rossari Biotech

Overall Rating

1. Quality

2. Valuation

Undervalued

3. Price Trend

Rossari Biotech Price Chart

P/E Ratio ( CD) :
37.45
Market Cap :
3,807.9 Cr.
52-wk low :
675
52-wk high :
1,250
Bole Toh?

1. Is Rossari Biotech Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Rossari Biotech Ltd is a average quality company.

2. Is Rossari Biotech Ltd undervalued or overvalued?

The key valuation ratios of Rossari Biotech Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is Rossari Biotech Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Rossari Biotech Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Rossari Biotech:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Rossari Biotech Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22TTM
ROCE % 0%8.3%7.9%7.2%21.6%29.2%39.2%27.6%21.4%16.1%-
Value Creation Index NA-0.4-0.4-0.50.51.11.81.00.60.2-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 01551711792332925166007091,4831,688
YoY Gr. Rt. %-NA10.4%4.4%30.6%25%76.9%16.3%18.2%109.1%-
Adj EPS 00.80.80.73.35.99.512.615.316.318.6
YoY Gr. Rt. %-NA-3.8%-7.9%364.3%81.9%60.1%33.1%21.8%6%-
BVPS (₹) 0100.6106.6113.6148.5214.525.656.478.3145.7155.9
Adj Net Profit 03.83.73.415.728.645.863.979.689.5102
Cash Flow from Ops. 015.28.125.77.223.671.256.847.829.4-
Debt/CF from Ops. 02.95.40.93.10.90.11.200.3-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA44.8%42.2%109.1%
Adj EPS NA38%19.8%6%
BVPS 0-0.478.686
Share Price - - - -43.2%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22TTM
Return on Equity % 087.7727.335.84231.122.914.712.3
Op. Profit Mgn % 09.58.6710.415.315.117.517.411.913.1
Net Profit Mgn % 02.52.21.96.79.88.910.711.266.1
Debt to Equity 010.90.50.30.200.200-
Working Cap Days 001531321071091071401631340
Cash Conv. Cycle 0081624245241329460

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 42.16%

Net Profit is growing at healthy rate in last 3 years 19.76%

Sales growth is good in last 4 quarters at 47.69%

Return on Equity has declined versus last 3 years average to 12.30%

Latest Financials - Rossari Biotech Ltd.

Standalone Consolidated
TTM EPS (₹) 11.8 18.6
TTM Sales (₹ Cr.) 973 1,688
BVPS (₹.) 148.2 155.9
Reserves (₹ Cr.) 807 849
P/BV 4.66 4.46
PE 58.47 37.45
From the Market
52 Week Low / High (₹) 675.00 / 1250.00
All Time Low / High (₹) 663.55 / 1620.60
Market Cap (₹ Cr.) 3,808
Equity (₹ Cr.) 11
Face Value (₹) 2
Industry PE 31.3

Management X-Ray of Rossari Biotech :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Rossari Biotech

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

News

Rossari Biotech Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Rossari Biotech on 06-Feb-2023 11:58 is : 691.7.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 06-Feb-2023 11:58 the market cap of Rossari Biotech stood at ₹ 3,807.9.
The latest PE ratio of Rossari Biotech as of 06-Feb-2023 11:58 is 58.47.
The latest PB ratio of Rossari Biotech as of 06-Feb-2023 11:58 is 4.66
The 52-week high of Rossari Biotech is ₹ 1,250 and the 52-week low is ₹ 675.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue / sales of Rossari Biotech is ₹ 973.2 ( Cr.) .

About Rossari Biotech Ltd

The company was initially incorporated as Rossari Labtech on March 6, 2003, as a partnership firm under the Indian Partnership Act, 1932, pursuant to a certificate of registration dated June 22, 2003, issued by the Registrar of Firms, Mumbai. The name of the partnership firm was changed to Rossari Biotech on December 5, 2003 and further the firm converted into a joint stock company on August 10, 2009, under part IX of the Companies Act, 1956 as Rossari Biotech Limited with a certificate of incorporation granted by the Registrar of Companies, Maharashtra at Mumbai (RoC). The company received its certificate of commencement of business on August 13, 2009.

Business area of the company

The company is one of the leading specialty chemicals manufacturing companies in India providing customized solutions to specific industrial and production requirements of its customers primarily in the FMCG, apparel, poultry and animal feed industries through its diversified product portfolio comprising home, personal care and performance chemicals; textile specialty chemicals; and animal health and nutrition products. The company’s business is organized in three main product categories - (i) home, personal care and performance chemicals; (ii) textile specialty chemicals; and (iii) animal health and nutrition products.

The company is the leading manufacturer of acrylic polymers in India and manufactures many products for its customers in the soaps and detergent, paints, inks and coatings, ceramics and tiles, water treatment chemicals and pulp and paper industries. It also manufacture institutional cleaning chemical formulations for hospitality, facility management, airports, corporates, food service, commercial laundry, malls, multiplexes, educational sector, places of worship etc. It is in advanced stages of expanding its home, personal care and performance product portfolio to water treatment formulations, specialty formulation for breweries as well as dairies. Besides, the company provides specialty chemicals for the entire value-chain of the textile industry starting from fiber, yarn to fabric, wet processing and garment processing. The company has also diversified into animal health and nutrition and currently supply poultry feed supplements and additives, pet grooming and pet treats including for weaning, infants and adult pets.

Major Events & Milestones:

  • 2003: The company’s Promoters entered into a partnership firm to start the manufacturers of specialty chemicals and industrial enzymes in India.
  • 2004: Established first manufacturing facility at Silvassa.
  • 2009: Conversion of partnership firm into company.
  • 2009: Incorporation of company.
  • 2009: Obtained recognition for in-house R&D unit from the Department of Scientific and Industrial Research.
  • 2010: Forayed into animal health and nutrition products.
  • 2013: Forayed into HPPC products.
  • 2014: The company’s Promoters entered into a Joint Venture with BUZIL-WERK Wagner GmbH & Co. KG to form Buzil Rossari.
  • 2015: Lease granted by GIDC to company for setting up manufacturing facility at Dahej.
  • 2017: The Food Safety Management System of Silvassa Manufacturing Facility has been assessed and found to conform to the requirements of ISO 9001:2015.
  • 2018: Entered into an exclusive purchasing agreement with Hindustan Unilever.
  • 2020: Completion of the Pre-IPO Placement.

Awards & accreditations:

  • 2009: The erstwhile Hon’ble Union Finance Minister Pranab Mukherjee awarded ‘Corp EXCEL 2008– National mSME’ form a list of 27000 companies.
  • 2010: Frost & Sullivan awarded ‘Customer Value Enhancement for Industrial Enzymes Market’.
  • 2011: The Council for Fair Business Practices awarded ‘CFBP – Jamnalal Bajaj Uchit Vyavahar Puraskar for Fair Business Practices’.
  • 2017: The India SME Forum awarded at the India SME 100 Awards for ‘scoring in the top 100 in the overall evaluation of Financial & Non - Financial Parameters amongst 33102 nominations’.
  • 2018: Arvind awarded ‘Star Performer Award 2018’ in the Dye & Chemicals Category.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now